MNPR EBITDA Growth
Monopar Therapeutics Inc · EBITDA Growth
MNPR EBITDA Growth
Year-over-year change vs the same period a year earlier
Latest reported-6.89%period ending
MNPR TTM EBITDA YoY % (-91.66% → -6.89%)
Year-over-year change
High-resolution chart · PNG
MNPR ebitda growth history
Trailing twelve months (TTM). Each value covers four complete reported quarters.
| Period ending | EBITDA Growth |
|---|---|
| -6.8859% | |
| 5.6108% | |
| 7.7892% | |
| -340.463% | |
| -232.0747% | |
| -190.864% | |
| -140.1529% | |
| 30.6113% | |
| 25.7684% | |
| 24.8876% | |
| 14.6771% | |
| 13.6919% | |
| -34.5495% | |
| -67.214% | |
| -91.4207% | |
| -91.7007% | |
| 7.1905% | |
| 9.4079% | |
| 5.4534% | |
| 26.5357% | |
| -50.4075% | |
| -122.7058% | |
| -263.2682% | |
| -24,743.1622% | |
| -8,081.7824% | |
| -3,030.9941% | |
| -1,510.2223% | |
| -5,198.2968% | |
| -130,448.5714% | |
| -95,638.6667% | |
| -14,356.5476% | |
| -115.4919% | |
| -100.5388% | |
| -101.1176% | |
| -91.6612% |